COVIVIO (COV.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:COV • FR0000064578

54.85 EUR
-0.05 (-0.09%)
Last: Feb 11, 2026, 05:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Taking everything into account, COV scores 4 out of 10 in our fundamental rating. COV was compared to 42 industry peers in the Diversified REITs industry. COV has a medium profitability rating, but doesn't score so well on its financial health evaluation. COV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • COV had positive earnings in the past year.
  • COV had a positive operating cash flow in the past year.
  • Of the past 5 years COV 4 years were profitable.
  • In the past 5 years COV always reported a positive cash flow from operatings.
COV.PA Yearly Net Income VS EBIT VS OCF VS FCFCOV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

  • COV has a Return On Assets (1.63%) which is in line with its industry peers.
  • COV has a Return On Equity (5.08%) which is in line with its industry peers.
  • With a Return On Invested Capital value of 3.21%, COV perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • COV had an Average Return On Invested Capital over the past 3 years of 2.97%. This is in line with the industry average of 3.45%.
  • The 3 year average ROIC (2.97%) for COV is below the current ROIC(3.21%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.63%
ROE 5.08%
ROIC 3.21%
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
COV.PA Yearly ROA, ROE, ROICCOV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 30.43%, COV is in line with its industry, outperforming 47.62% of the companies in the same industry.
  • In the last couple of years the Profit Margin of COV has declined.
  • COV has a Operating Margin of 57.80%. This is in the lower half of the industry: COV underperforms 61.90% of its industry peers.
  • In the last couple of years the Operating Margin of COV has remained more or less at the same level.
  • With a Gross Margin value of 74.42%, COV perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
  • COV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 57.8%
PM (TTM) 30.43%
GM 74.42%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
COV.PA Yearly Profit, Operating, Gross MarginsCOV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • COV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, COV has more shares outstanding
  • The number of shares outstanding for COV has been increased compared to 5 years ago.
  • The debt/assets ratio for COV has been reduced compared to a year ago.
COV.PA Yearly Shares OutstandingCOV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
COV.PA Yearly Total Debt VS Total AssetsCOV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

  • Based on the Altman-Z score of 0.53, we must say that COV is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.53, COV is doing worse than 69.05% of the companies in the same industry.
  • COV has a debt to FCF ratio of 28.49. This is a negative value and a sign of low solvency as COV would need 28.49 years to pay back of all of its debts.
  • COV's Debt to FCF ratio of 28.49 is on the low side compared to the rest of the industry. COV is outperformed by 69.05% of its industry peers.
  • COV has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
  • COV has a Debt to Equity ratio of 1.07. This is in the lower half of the industry: COV underperforms 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 28.49
Altman-Z 0.53
ROIC/WACC0.55
WACC5.82%
COV.PA Yearly LT Debt VS Equity VS FCFCOV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 0.76 indicates that COV may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.76, COV is in the better half of the industry, outperforming 69.05% of the companies in the same industry.
  • A Quick Ratio of 0.69 indicates that COV may have some problems paying its short term obligations.
  • COV's Quick ratio of 0.69 is fine compared to the rest of the industry. COV outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.69
COV.PA Yearly Current Assets VS Current LiabilitesCOV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • COV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.98%.
  • The Earnings Per Share has been decreasing by -3.39% on average over the past years.
  • The Revenue has grown by 27.96% in the past year. This is a very strong growth!
  • Measured over the past years, COV shows a small growth in Revenue. The Revenue has been growing by 1.17% on average per year.
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 3.53% on average over the next years.
  • The Revenue is expected to grow by 4.10% on average over the next years.
EPS Next Y5.02%
EPS Next 2Y3.41%
EPS Next 3Y3.53%
EPS Next 5YN/A
Revenue Next Year1.77%
Revenue Next 2Y3.17%
Revenue Next 3Y4.1%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
COV.PA Yearly Revenue VS EstimatesCOV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
COV.PA Yearly EPS VS EstimatesCOV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.90, the valuation of COV can be described as very reasonable.
  • Based on the Price/Earnings ratio, COV is valued a bit cheaper than 66.67% of the companies in the same industry.
  • COV is valuated cheaply when we compare the Price/Earnings ratio to 28.03, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 11.47, the valuation of COV can be described as reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of COV indicates a somewhat cheap valuation: COV is cheaper than 61.90% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.97, COV is valued rather cheaply.
Industry RankSector Rank
PE 11.9
Fwd PE 11.47
COV.PA Price Earnings VS Forward Price EarningsCOV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • COV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. COV is cheaper than 66.67% of the companies in the same industry.
  • COV's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 15.59
EV/EBITDA 16.9
COV.PA Per share dataCOV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.37
PEG (5Y)N/A
EPS Next 2Y3.41%
EPS Next 3Y3.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • COV has a Yearly Dividend Yield of 6.44%, which is a nice return.
  • COV's Dividend Yield is a higher than the industry average which is at 5.29.
  • Compared to an average S&P500 Dividend Yield of 1.80, COV pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.44%

5.2 History

  • The dividend of COV decreases each year by -1.54%.
Dividend Growth(5Y)-1.54%
Div Incr Years2
Div Non Decr Years2
COV.PA Yearly Dividends per shareCOV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

  • COV pays out 92.86% of its income as dividend. This is not a sustainable payout ratio.
DP92.86%
EPS Next 2Y3.41%
EPS Next 3Y3.53%
COV.PA Yearly Income VS Free CF VS DividendCOV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
COV.PA Dividend Payout.COV.PA Dividend Payout, showing the Payout Ratio.COV.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

COVIVIO

EPA:COV (2/11/2026, 5:36:15 PM)

54.85

-0.05 (-0.09%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)N/A
Earnings (Next)02-18
Inst Owners42.11%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap6.12B
Revenue(TTM)1.37B
Net Income(TTM)417.40M
Analysts80
Price Target63.81 (16.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.44%
Yearly Dividend0.72
Dividend Growth(5Y)-1.54%
DP92.86%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.39%
PT rev (3m)-0.96%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.04%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.88%
Valuation
Industry RankSector Rank
PE 11.9
Fwd PE 11.47
P/S 4.46
P/FCF 15.59
P/OCF 6.1
P/B 0.74
P/tB 0.78
EV/EBITDA 16.9
EPS(TTM)4.61
EY8.4%
EPS(NY)4.78
Fwd EY8.72%
FCF(TTM)3.52
FCFY6.41%
OCF(TTM)8.99
OCFY16.39%
SpS12.29
BVpS73.66
TBVpS70.57
PEG (NY)2.37
PEG (5Y)N/A
Graham Number87.41
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 5.08%
ROCE 3.59%
ROIC 3.21%
ROICexc 3.42%
ROICexgc 3.48%
OM 57.8%
PM (TTM) 30.43%
GM 74.42%
FCFM 28.62%
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
ROICexc(3y)3.08%
ROICexc(5y)2.79%
ROICexgc(3y)3.11%
ROICexgc(5y)2.81%
ROCE(3y)3.32%
ROCE(5y)3%
ROICexgc growth 3Y12.16%
ROICexgc growth 5Y0.31%
ROICexc growth 3Y11.77%
ROICexc growth 5Y0.14%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 28.49
Debt/EBITDA 9.39
Cap/Depr 415.79%
Cap/Sales 44.53%
Interest Coverage 250
Cash Conversion 106.78%
Profit Quality 94.06%
Current Ratio 0.76
Quick Ratio 0.69
Altman-Z 0.53
F-Score7
WACC5.82%
ROIC/WACC0.55
Cap/Depr(3y)709.28%
Cap/Depr(5y)708.5%
Cap/Sales(3y)50.08%
Cap/Sales(5y)56.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
EPS Next Y5.02%
EPS Next 2Y3.41%
EPS Next 3Y3.53%
EPS Next 5YN/A
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%
Revenue Next Year1.77%
Revenue Next 2Y3.17%
Revenue Next 3Y4.1%
Revenue Next 5YN/A
EBIT growth 1Y-0.75%
EBIT growth 3Y7.42%
EBIT growth 5Y0.05%
EBIT Next Year12.83%
EBIT Next 3Y8.07%
EBIT Next 5Y7.52%
FCF growth 1Y41.8%
FCF growth 3YN/A
FCF growth 5Y31.13%
OCF growth 1Y30.51%
OCF growth 3Y12.5%
OCF growth 5Y4.86%

COVIVIO / COV.PA FAQ

Can you provide the ChartMill fundamental rating for COVIVIO?

ChartMill assigns a fundamental rating of 4 / 10 to COV.PA.


What is the valuation status for COV stock?

ChartMill assigns a valuation rating of 5 / 10 to COVIVIO (COV.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for COVIVIO?

COVIVIO (COV.PA) has a profitability rating of 4 / 10.


What is the financial health of COVIVIO (COV.PA) stock?

The financial health rating of COVIVIO (COV.PA) is 1 / 10.


How sustainable is the dividend of COVIVIO (COV.PA) stock?

The dividend rating of COVIVIO (COV.PA) is 4 / 10 and the dividend payout ratio is 92.86%.